A 28-year-old multiparous woman at 38 weeks gestation presents with vaginal bleeding and abdominal pain. She delivers a stillborn infant 4 hours later. Postpartum, she has severe ongoing bleeding with a platelet count of 85,000/µL, PT 18 sec (control 12 sec), aPTT 45 sec (control 32 sec), and fibrinogen 120 mg/dL. Which laboratory finding best distinguishes disseminated intravascular coagulation (DIC) secondary to placental abruption from consumptive coagulopathy due to massive transfusion?

Explanation

## DIC vs. Massive Transfusion Coagulopathy ### Key Discriminating Laboratory Profile **Key Point:** The combination of severely low fibrinogen (<100 mg/dL), markedly elevated D-dimer, and thrombocytopenia is the best discriminator of DIC. In massive transfusion coagulopathy, fibrinogen is diluted but remains relatively higher, and D-dimer elevation is less pronounced. ### Comparative Laboratory Table | Parameter | DIC (Abruption) | Massive Transfusion Coagulopathy | | --- | --- | --- | | **Fibrinogen** | Severely low (<100 mg/dL) | Mildly-moderately low (100–200 mg/dL) | | **D-dimer** | Markedly elevated (>10 µg/mL) | Mildly elevated | | **Platelets** | <100,000/µL (consumption) | <100,000/µL (dilution) | | **PT/aPTT** | Prolonged | Prolonged | | **Schistocytes** | Present (microangiopathy) | Absent | | **FDP** | Markedly elevated | Mildly elevated | | **Mechanism** | Thrombin generation → consumption | Dilution of clotting factors | ### Clinical Pearl **Clinical Pearl:** In placental abruption-induced DIC, the pathophysiology is **activation** (tissue factor release from placental injury triggers massive thrombin generation and consumption of platelets and fibrinogen). In massive transfusion, the mechanism is **dilution** (replacement of blood with crystalloid/RBC products dilutes remaining clotting factors). The fibrinogen level and D-dimer magnitude reflect this difference. ### High-Yield Distinction **High-Yield:** Fibrinogen <100 mg/dL with D-dimer >10 µg/mL is virtually diagnostic of DIC and not seen in simple dilutional coagulopathy. Massive transfusion typically preserves fibrinogen >100 mg/dL because FFP is administered early. ### Pathophysiology ```mermaid flowchart TD A[Placental Abruption]:::outcome --> B[Tissue Factor Release]:::action B --> C[Thrombin Cascade Activation]:::action C --> D[Consumption of Fibrinogen, Platelets, Factors]:::action D --> E[Fibrinogen &lt;&lt; 100 mg/dL<br/>D-dimer &gt;&gt; 10 µg/mL<br/>Platelets &lt; 100K]:::urgent F[Massive Hemorrhage + Transfusion]:::outcome --> G[Dilution of Clotting Factors]:::action G --> H[RBC/Crystalloid Replaces Plasma]:::action H --> I[Fibrinogen 100–200 mg/dL<br/>D-dimer mildly elevated<br/>Platelets &lt; 100K]:::outcome ``` **Mnemonic:** DIC = **D**ecrease fibrinogen (severe), **I**ncreased D-dimer (marked), **C**onsumptive (not dilutional) process.